Skip to main content
. 2022 Feb 13;19(4):2096. doi: 10.3390/ijerph19042096

Table 2.

Comparison of blood parameters among MAFLD and non-MAFLD participants.

Blood Parameters All MAFLD Non-MAFLD p
Waist-to-hip ratio 0.87 ± 0.71 0.91 ± 0.06 0.86 ± 0.07 <0.001
ALT (IU/L) 22.35 ± 19.78 29.62 ± 25.92 18.87 ± 14.80 <0.001
AST(IU/L) 22.12 ± 12.99 24.58 ± 16.29 20.94 ± 10.86 <0.001
TP (g/L) 77.74 ± 4.90 78.17 ± 4.91 77.53 ± 4.88 <0.001
ALB (g/L) 48.70 ± 3.17 48.60 ± 3.28 48.75 ± 3.11 <0.001
TBIL (umol/L) 12.36 ± 5.17 12.20 ± 5.22 12.43 ± 5.14 <0.001
DBIL (umol/L) 3.62 ± 1.79 3.53 ± 1.83 3.66 ± 1.77 <0.001
IBIL (umol/L) 8.74 ± 3.78 8.68 ± 3.82 8.77 ± 3.75 0.001
ALP (IU/L) 86.08 ± 26.55 91.15 ± 26.56 83.65 ± 26.20 <0.001
GGT (IU/L) 31.61 ± 37.35 41.33 ± 42.32 26.95 ± 33.73 <0.001
TBA (umol/L) 3.82 ± 4.29 4.08 ± 4.64 3.70 ± 4.10 <0.001
CHE (IU/L) 8326.54 ± 1550.40 9021.44 ± 1472.02 7993.57 ± 1474.81 <0.001
PA (g/L) 0.29 ± 0.05 0.30 ± 0.05 0.28 ± 0.05 <0.001
TG (umol/L) 1.66 ± 1.69 2.26 ± 2.23 1.37 ± 1.26 <0.001
FPG (mmol/L)) 5.96 ± 1.81 6.40 ± 2.11 5.75 ± 1.60 <0.001
CHOL (mmo/L) 5.07 ± 1.02 5.23 ± 1.06 4.99 ± 0.99 <0.001
HDL-C (mmo/L) 1.38 ± 0.33 1.26 ± 0.29 1.43 ± 0.34 <0.001
LDL-C (mmo/L) 2.96 ± 0.84 3.14 ± 0.85 2.87 ± 0.82 <0.001
HbA1c (%) 5.56 ± 0.98 5.81 ± 1.14 5.44 ± 0.88 <0.001
RBC× (1012/L) 4.71 ± 0.46 4.82 ± 0.46 4.66 ± 0.45 <0.001
HGB (g/L) 135.89 ± 15.30 139.11 ± 14.92 134.34 ± 15.25 0.018
HCT (%) 0.40 ± 0.04 0.41 ± 0.04 0.39 ± 0.04 0.012
MCV (fl) 84.71 ± 4.59 84.48 ± 4.27 84.82 ± 4.73 <0.001
MCH (pg) 28.91 ± 3.47 28.91 ± 4.58 28.90 ± 2.78 0.002
MCHC (g/L) 340.95 ± 35.77 341.94 ± 53.71 340.48 ± 22.57 0.68
RDW (%) 0.11 ± 0.01 0.11 ± 0.01 0.11 ± 0.01 0.001
PLT (×109/L) 218.14 ± 55.25 219.93 ± 58.53 217.28 ± 53.59 <0.001
PDW (%) 0.20 ± 0.01 0.20 ± 0.01 0.20 ± 0.01 0.003
MPV (fl) 6.40 ± 1.12 6.40 ± 1.11 6.41 ± 1.13 0.41
PCT (%) 0.14 ± 0.05 0.14 ± 0.07 0.14 ± 0.04 <0.001
WBC (×109/L) 6.35 ± 1.66 6.75 ± 1.70 6.15 ± 1.60 <0.001
LYM (×109/L) 2.15 ± 0.66 2.29 ± 0.68 2.08 ± 0.64 <0.001
MONO (×109/L) 0.40 ± 0.16 0.42 ± 0.16 0.39 ± 0.16 <0.001
NEU (×109/L) 3.60 ± 1.25 3.83 ± 1.27 3.50 ± 1.23 <0.001
EOS (×109/L) 0.14 ± 0.14 0.15 ± 0.16 0.13 ± 0.13 <0.001
BASO (×109/L) 0.06 ± 0.05 0.06 ± 0.06 0.06 ± 0.05 <0.001
AFP (ng/mL) 3.50 ± 9.49 3.66 ± 16.13 3.43 ± 2.91 0.06
Alcohol_consumption (g) 6.62 ± 22.13 8.07 ± 24.83 5.93 ± 20.68 <0.001
LSM (Kpa) 6.53 ± 2.83 7.41 ± 3.17 6.10 ± 2.55 <0.001
UAP (dB/m) 230.14 ± 38.33 275.04 ± 25.46 208.62 ± 20.81 <0.001

ALT—alanine aminotransferase; AST—aspartate aminotransferase; TP—total proten; ALB—album; BIL—total bilirubin; DBIL—total bilirubin; IBIL—total bilirubin; ALP—alkaline phosphatase; GGT—gamma-glutamyltransferase; TBA—total bile acids; CHE—cholinesterase; PA—polymerase acidic protein; TG—triglyceride; FPG—fasting plasma glucose; CHOL—cholesterol; HDL-C—high-density lipoprotein cholesterol; LDL-C—low-density lipoprotein cholesterol; HbA1c—hemoglobin A1C; RBC—red blood cell count; HGB—hemoglobin; HCT—hematocrit; MCV—erythrocyte mean corpuscular volume; MCH—mean corpuscular hemoglobin; MCHC—mean erythrocyte hemoglobin concentration; RDW—width of red blood cell volume distribution; PLT—platelets; PDW—width of platelet volume distribution; MPV—mean platelet volume; PCT—procalcitonin; WBC—white blood cell; LYM—lymphocytes count; MONO—monocytes count; NEUT—neutrophils count; EOS—eosinophils count; BASO—basophils count; AFP—alpha-fetoprotein; LSM—liver fibrosis; UAP—ultrasound attenuation parameter.